Table 6.
Neoplasm | Zhong (1996) | Sugiyama (1999) | Adsay (2002) | Osanai (2003) | Kamisawa (2005) | Egichi (2006) | Choi (2006) | Yoon (2008) | Ishida (2008) | Present study | Total |
Gastric cancer | 0 | 4 | 0 | 8 | 12 | 4 | 8 | 29 | 6 | 13 | 84 |
Colon cancer | 3 | 5 | 0 | 11 | 7 | 8 | 4 | 16 | 4 | 8 | 66 |
Lung cancer | 0 | 1 | 1 | 5 | 4 | 5 | 0 | 3 | 1 | 5 | 25 |
Bile duct cancer | 0 | 1 | 0 | 4 | 1 | NS | 2 | 8 | 1 | 1 | 18 |
Prostate cancer | 0 | 1 | 1 | 2 | 1 | 2 | 0 | 1 | 0 | 3 | 11 |
Renal cancer | 0 | 1 | 1 | 2 | 0 | 2 | 0 | 3 | 1 | 1 | 11 |
Breast cancer | 0 | 1 | 0 | 0 | 2 | NS | 0 | 0 | 0 | 7 | 10 |
Esophageal cancer | 2 | 0 | 0 | 2 | 4 | NS | 0 | 0 | 1 | 0 | 9 |
Malignant lymphoma | 0 | 0 | 0 | 0 | 1 | NS | 2 | 4 | 1 | 1 | 9 |
Bladder cancer | 0 | 1 | 1 | 0 | 0 | 2 | 1 | 1 | 0 | 1 | 7 |
Liver cancer | 0 | 0 | 0 | 1 | 2 | NS | 0 | 1 | 1 | 1 | 6 |
Thyroid cancer | 0 | 0 | 0 | 0 | 0 | NS | 1 | 3 | 0 | 1 | 5 |
Ampullary cancer | 0 | 0 | 1 | 0 | 0 | NS | 0 | 3 | 1 | 0 | 5 |
Skin cancer | 0 | 0 | 1 | 0 | 0 | NS | 0 | 1 | 0 | 2 | 4 |
Uterine cancer | 0 | 0 | 0 | 0 | 1 | NS | 0 | 2 | 0 | 0 | 3 |
Laryngeal cancer | 0 | 0 | 0 | 0 | 1 | NS | 0 | 0 | 0 | 1 | 2 |
Pharyngeal cancer | 0 | 0 | 0 | 0 | 1 | NS | 0 | 0 | 0 | 1 | 2 |
Ovarian cancer | 0 | 0 | 0 | 0 | 0 | NS | 0 | 1 | 0 | 0 | 1 |
Duodenal cancer | 0 | 0 | 0 | 0 | 0 | NS | 0 | 1 | 0 | 0 | 1 |
Other cancer or unknown | 0 | 0 | 2 | 0 | 0 | 9 | 0 | 0 | 0 | 0 | 11 |
Total | 5 | 15 | 8 | 35 | 37 | 32 | 18 | 77 | 17 | 46 | 290 |